H.C. Wainwright analyst Yi Chen initiated coverage of Bionano Genomics (BNGO) with a Buy rating and $10 price target Bionano is a ...

Fintel reports that on April 9, 2025, HC Wainwright & Co. initiated coverage of Bionano Genomics (NasdaqCM:BNGO) with a Buy recommendation. Analyst Price Forecast Suggests 2,062.54% Upside As of April ...

Thank you, operator, and good afternoon, everyone. Welcome to the Bionano fourth quarter 2024 financial results conference ...

Bionano Genomics (BNGO) announced a study published in The Journal of Molecular Diagnostics that describes a method for analysis of multiple ...

Conference call today, March 31, 2025 at 4:30 PM ETSAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and ...

Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano ...

Discover Bionano Genomics' Q4 2024 earnings insights, focusing on operational efficiency, core customer utilization, and 2025 growth strategies with new ...

Shares of NASDAQ:BNGO opened at $3.36 on Wednesday. Bionano Genomics has a 52-week low of $2.68 and a 52-week high of $72.60. The stock has a market cap of $9.18 million, a P/E ratio of -0.02 and ...

SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study published in The Journal of Molecular Diagnostics that describes a method for analysis of ...

Q4 2024 Earnings Call Transcript March 31, 2025 Bionano Genomics, Inc. reports earnings inline with expectations. Reported ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bionano Genomics wasn’t one of them. The 10 stocks that made ...

Good day, and welcome to the Bionano Fourth Quarter 2024 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...